In an interview to Bloomberg, Ken Feinberg, the mediator who is negotiating between cancer victims and Bayer stated, the the German pharmaceutical and life sciences company is close to settling more than 75,000 cancer claims related to its Roundup herbicide, while adding that he was “cautiously optimistic” that a deal could be reached within a month.
Feinberg has been quoted as saying that the number of cases had grown to between 75,000 and 85,000 and “maybe more”.
In October 2019, Bayer had said it was now facing 42,700 U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer.
Feinberg declined to discuss terms of any potential settlement.
Bayer has ruled out withdrawing from the U.S. market, saying regulators and extensive research have found glyphosate to be safe.
“The number reported by Bloomberg includes potential plaintiffs with unserved cases and is a speculative estimate about the numbers of plaintiffs who might be included in a potential settlement,” said Bayer’s spokesman while adding, “The number of served cases as reported on a quarterly basis remains significantly below 50,000. Bayer does not report or speculate about potential plaintiffs with unserved cases.”